drugset / Trial / NCT06837844

Combined Intrathecal Dexmedetomidine and Adductor Canal Block for Analgesia After Total Knee Arthroplasty

NCT06837844 ↗

Recruiting 75 enrolled Kafrelsheikh University
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of this work is to evaluate the effect of combined intrathecal dexmedetomidine and adductor canal block for analgesia after total knee arthroplasty (TKA).

Timeline

Start
2025-02-20
Primary completion
2025-08-01
Completion
2025-08-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 15 mg Intrathecal
Comparator Bupivacaine Other / unclassified 20 ml Intrathecal
Subject Dexmedetomidine Other / unclassified 5 ug Intrathecal

Indications

No indication recorded.